It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Retraction Note: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
Author
Xu, Xuefen 1 ; Zhang, Xiaobo 1 ; Zhang, Yi 1 ; Yang, Lin 1 ; Liu, Yicheng 1 ; Huang, Shaoliang 1 ; Lu, Lu 1 ; Kong, Lingyi 2 ; Li, Zhiyu 2 ; Guo, Qinglong 1 ; Zhao, Li 1
1 China Pharmaceutical University, State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Nanjing, People’s Republic of China (GRID:grid.254147.1) (ISNI:0000 0000 9776 7793)
2 China Pharmaceutical University, State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, Nanjing, People’s Republic of China (GRID:grid.254147.1) (ISNI:0000 0000 9776 7793)
1 China Pharmaceutical University, State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Nanjing, People’s Republic of China (GRID:grid.254147.1) (ISNI:0000 0000 9776 7793)
2 China Pharmaceutical University, State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, Nanjing, People’s Republic of China (GRID:grid.254147.1) (ISNI:0000 0000 9776 7793)
Publication year
2022
Publication date
2022
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2671450515
Copyright
© The Publisher 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.